These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 34198132)
21. Provider-directed marketing may increase prescribing of medications for opioid use disorder. Nguyen T; Andraka-Christou B; Simon K; Bradford WD J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974 [TBL] [Abstract][Full Text] [Related]
22. Predictors of availability of long-acting medication for opioid use disorder. Shover CL; Humphreys K Drug Alcohol Depend; 2019 Nov; 204():107586. PubMed ID: 31593871 [TBL] [Abstract][Full Text] [Related]
23. The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review. Russell C; Law J; Imtiaz S; Rehm J; Le Foll B; Ali F Addict Sci Clin Pract; 2023 Aug; 18(1):48. PubMed ID: 37587456 [TBL] [Abstract][Full Text] [Related]
24. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402 [TBL] [Abstract][Full Text] [Related]
25. A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States. Gaeta Gazzola M; Carmichael ID; Christian NJ; Zheng X; Madden LM; Barry DT Subst Abus; 2023; 44(1):62-72. PubMed ID: 37226909 [TBL] [Abstract][Full Text] [Related]
26. The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity. Hoang BL; Sledge D Drug Alcohol Depend Rep; 2022 Sep; 4():100081. PubMed ID: 36846575 [TBL] [Abstract][Full Text] [Related]
27. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial. Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642 [TBL] [Abstract][Full Text] [Related]
28. Medications for Opioid Use Disorder after Entering Residential Treatment: Evidence from Louisiana Medicaid. Li W; Eisenberg M; Song M; Kennedy-Hendricks A; Saloner B J Addict Med; 2024 Aug; ():. PubMed ID: 39150076 [TBL] [Abstract][Full Text] [Related]
29. Medications for opioid use disorder in pregnancy in a state women's prison facility. Knittel AK; Zarnick S; Thorp JM; Amos E; Jones HE Drug Alcohol Depend; 2020 Sep; 214():108159. PubMed ID: 32683223 [TBL] [Abstract][Full Text] [Related]
30. Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders. Mark TL; Goode SA; McMurtrie G; Weinstein L; Perry RJ J Addict Med; 2023 May-Jun 01; 17(3):249-257. PubMed ID: 37267162 [TBL] [Abstract][Full Text] [Related]
31. Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff. Andraka-Christou B; Atkins D; Madeira J; Silverman RD Drug Alcohol Rev; 2020 Jul; 39(5):583-587. PubMed ID: 32394525 [TBL] [Abstract][Full Text] [Related]
32. Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder. Andraka-Christou B; Nguyen T; Bradford DW; Simon K J Subst Abuse Treat; 2020 Mar; 110():49-58. PubMed ID: 31952628 [TBL] [Abstract][Full Text] [Related]
33. Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse. Singhal A; Tien YY; Hsia RY PLoS One; 2016; 11(8):e0159224. PubMed ID: 27501459 [TBL] [Abstract][Full Text] [Related]
34. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS; Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443 [TBL] [Abstract][Full Text] [Related]
35. Health Savings Plans and Disparities in Access to Care by Race and Ethnicity. Ortiz SE; Segel JE; Tran LM Am J Prev Med; 2021 Aug; 61(2):e81-e92. PubMed ID: 33985836 [TBL] [Abstract][Full Text] [Related]
36. The intersection of race and opioid use disorder treatment: A quantitative analysis. Entress RM J Subst Abuse Treat; 2021 Dec; 131():108589. PubMed ID: 34426022 [TBL] [Abstract][Full Text] [Related]
37. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation. Ahn J; Liu B; Bhuket T; Wong RJ Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576 [TBL] [Abstract][Full Text] [Related]
38. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder. Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058 [TBL] [Abstract][Full Text] [Related]
39. Racial and Ethnic Disparities in Opioid Prescribing for Long Bone Fractures at Discharge From the Emergency Department: A Cross-sectional Analysis of 22 Centers From a Health Care Delivery System in Northern California. Romanelli RJ; Shen Z; Szwerinski N; Scott A; Lockhart S; Pressman AR Ann Emerg Med; 2019 Nov; 74(5):622-631. PubMed ID: 31272820 [TBL] [Abstract][Full Text] [Related]
40. U.S. alcohol treatment admissions after the Mental Health Parity and Addiction Equity Act: Do state parity laws and race/ethnicity make a difference? Mulia N; Lui CK; Ye Y; Subbaraman MS; Kerr WC; Greenfield TK J Subst Abuse Treat; 2019 Nov; 106():113-121. PubMed ID: 31451310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]